Mohammad H Mir, Parvaiz A Rather, Farhana Bagdadi.
Sunitinib-induced hand-foot syndrome in a Kashmiri male .
J Pak Assoc Derma Jan ;24(2):180-2.

Sunitinib belongs to multiple tyrosine kinase inhibitor class of novel targeted therapies used for metastatic solid tumours including renal cell carcinoma. A variety of systemic, as well as, cutaneous side effects due to sunitinib have been described including the hand foot syndrome. We report sunitinib-induced hand foot syndrome in a 65-year-old Kashmiri male and review the literature.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com